Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOCS
1951
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $2.62M | ﹤0.01% |
50,550
+34,972
| +224% | +$1.69M |
|
|
PWSC
1952
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $2.62M | ﹤0.01% |
132,213
+113,284
| +598% | +$2.48M |
|
|
SHAP.WS
1953
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
| $2.62M | ﹤0.01% |
250,273
-19,000
| -7% | -$705 |
|
1954
CALL
HP
HPQ
$24.8B
| $2.61M | ﹤0.01% |
89,000
-195,800
| -69% | -$5.62M |
|
1955
Madison Square Garden
MSGS
$9.27B
| $2.61M | ﹤0.01% |
13,395
-234
| -2% | -$43.6K |
|
1956
Outfront Media
OUT
$5.61B
| $2.6M | ﹤0.01% |
162,518
-309,777
| -66% | -$5.42M |
|
|
ABPWW
1957
DELISTED
Abpro Holdings Warrant
ABPWW
| $2.6M | ﹤0.01% |
250,000
| – | – |
|
|
KZR
1958
DELISTED
Kezar Life Sciences
KZR
| $2.59M | ﹤0.01% |
82,903
+64,154
| +342% | +$3.71M |
|
1959
Ziff Davis
ZD
$1.99B
| $2.59M | ﹤0.01% |
33,188
+13,112
| +65% | +$1.07M |
|
1960
Bausch Health
BHC
$2.62B
| $2.59M | ﹤0.01% |
319,675
+924
| +0.3% | +$7.42K |
|
|
VCXB.WS
1961
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
| $2.59M | ﹤0.01% |
250,000
| – | – |
|
1962
Under Armour Class C
UA
$2.83B
| $2.58M | ﹤0.01% |
303,046
+228,535
| +307% | +$2.1M |
|
1963
ATI
ATI
$26.4B
| $2.58M | ﹤0.01% |
65,341
-27,474
| -30% | -$1.04M |
|
1964
Kontoor Brands
KTB
$4.68B
| $2.58M | ﹤0.01% |
53,275
+18,003
| +51% | +$853K |
|
|
NBIS
1965
Nebius Group N.V.
NBIS
$54B
| $2.58M | ﹤0.01% |
135,957
-13,274
| -9% | -$251K |
|
1966
Semtech
SMTC
$11.1B
| $2.57M | ﹤0.01% |
106,650
-5,872
| -5% | -$184K |
|
1967
PUT
Workday
WDAY
$40.8B
| $2.56M | ﹤0.01% |
+12,400
| New | +$2.26M |
|
1968
Group 1 Automotive
GPI
$3.48B
| $2.56M | ﹤0.01% |
11,299
+3,209
| +40% | +$681K |
|
1969
CALL
Chewy
CHWY
$9.4B
| $2.56M | ﹤0.01% |
68,400
-460,900
| -87% | -$19.1M |
|
1970
Hanover Insurance
THG
$8.09B
| $2.56M | ﹤0.01% |
19,895
+1,483
| +8% | +$199K |
|
1971
Iovance Biotherapeutics
IOVA
$1.93B
| $2.55M | ﹤0.01% |
417,160
-213,790
| -34% | -$1.48M |
|
1972
PUT
Nucor
NUE
$59.5B
| $2.55M | ﹤0.01% |
+16,500
| New | +$2.62M |
|
1973
Bankunited
BKU
$3.4B
| $2.55M | ﹤0.01% |
112,747
+45,999
| +69% | +$1.5M |
|
1974
Azenta
AZTA
$1.38B
| $2.54M | ﹤0.01% |
56,991
+46,920
| +466% | +$2.32M |
|
|
BLU
1975
DELISTED
BELLUS Health Inc.
BLU
| $2.54M | ﹤0.01% |
353,021
+71,829
| +26% | +$557K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.